发明授权
US07968281B2 Methods of modulating SMYD3 for treatment of cancer 有权
调节SMYD3治疗癌症的方法

Methods of modulating SMYD3 for treatment of cancer
摘要:
The present invention features a method for determining the methyltransferase activity of a polypeptide and screening for modulators of methyltransferase activity, more particularly for modulators of the methylation of retinoblastoma by SMYD3. The invention further provides a method or pharmaceutical composition for prevention or treating of colorectal cancer, hepatocellular carcinoma, bladder cancer and/or breast cancer using a modulator so identified. N-terminal truncated forms of SMYD3 (alias ZNFN3A1) have higher methylating activity. Lys 824 is a preferred methylation site on the RB1 protein for SMYD3.
公开/授权文献
信息查询
0/0